Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.

About this trial

Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.

The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ability to understand and the willingness to sign a written informed consent document

Participant must be 18 years of age or older

Confirmed diagnosis of atopic dermatitis

Disqualifiers

Enrolled in another research study

Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study

Inability to provide written informed consent

Trial population

Patients with atopic dermatitis who are actively considering enrolling in a clinical study for said condition, but have not yet completed enrollment and randomization.

Trial design

Design model

Case-crossover

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Number of atopic dermatitis patients who decide to enroll in a clinical research

Time frame
3 months
2

Rate of atopic dermatitis patients who remain in clinical trial to trial completion

Time frame
12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: